You are invited to join Health Affairs and the National Pharmaceutical Council on September 11 in Washington, DC for an important event, "Health Spending: Moving From Theory to Action."
Eighteen months ago, Health Affairs teamed with the National Pharmaceutical Council and Anthem, Inc. to launch a multi-year project to promote an evidence-based conversation about health spending. The project explores questions involving the level and growth rate of health spending, the distribution of spending, efforts to improve the value of care, and analysis of options for constraining health care costs. The project has produced content in the journal as well as the blog and includes creation of the Health Affairs Council on Health Care Spending and Value.
To continue the conversation that began at last year's standing-room-only launch event and to build on the related work described above, Health Affairs and the National Pharmaceutical Council are hosting a forum that will address:
- The pressures presented by soaring health costs on individuals, employers, and government
- Strategies among payers and others to promote cost effective care
- Efforts currently underway to bring costs under control
- Mandy Cohen (left), Secretary, North Carolina Department of Health and Human Services
- Patrick Conway (2nd from left), President and CEO, Blue Cross and Blue Shield of North Carolina
- Robert W. Dubois (middle), Executive Vice President and Chief Science Officer, National Pharmaceutical Council
- Christopher F. Koller (2nd from right), President, Milbank Memorial Fund
- Reed Tuckson (right), Managing Director, Tuckson Health Connections, LLC
- Alan Weil, Editor-in-Chief, Health Affairs
Questions should be emailed to firstname.lastname@example.org.
ABOUT HEALTH AFFAIRS
Health Affairs is the leading peer-reviewed journal at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online.
ABOUT THE NATIONAL PHARMACEUTICAL COUNCIL
The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation's major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients.